L
LianBio
Focused on bringing paradigm-shifting medicines to patients
About LianBio
LianBio operates at the intersection of global biotech innovation and the expansive healthcare market in China and major Asian regions. The company focuses on identifying and sourcing top-tier therapeutic opportunities and creating new treatment paradigms for first-in-class programs. LianBio's unique business model is designed to support leading biotech companies that have not previously engaged in development within China and other major Asian markets. By leveraging a global innovation mining platform and a China-centric execution strategy, LianBio facilitates access to these large and dynamic healthcare landscapes, enhancing global development initiatives for its partners.
LianBio serves biotech companies looking to expand their reach into the Asian healthcare market. The company operates in the healthcare and biotechnology sectors, focusing on unmet medical needs and innovative treatment approaches. Its business model revolves around strategic and financial partnerships, enabling it to bring advanced medical science to patients in need. Revenue is generated through these partnerships, which often involve collaborative development and commercialization agreements.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2021
News
Open roles
LianBio in the Pudong ecosystem
The LianBio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later14 investors entered at this stage
BlackRock
Perceptive Advisors
Sphera Funds Management
Logos Capital
Venrock
Tybourne Capital Management
Casdin Capital
Viking Global Investors
Farallon Capital Management
Wellington Management
Pfizer
RA Capital Management
Vida Ventures
T. Rowe Price
Source: Dealroom Talent Intelligence.
See LianBio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


